Endoscopic submucosal excavation for gastric plexiform fibromyxoma: A case report and systematic review of literature

Ziqin Xia; Zhidai Zhou; Wei Guo; Hongling Wang; Fan Wang; Feng Zhou

doi:10.3389/fonc.2023.1090259

Endoscopic submucosal excavation for gastric plexiform fibromyxoma: A case report and systematic review of literature

Front Oncol. 2023 Mar 24:13:1090259. doi: 10.3389/fonc.2023.1090259. eCollection 2023.

Authors

Ziqin Xia¹, Zhidai Zhou¹, Wei Guo², Hongling Wang¹, Fan Wang¹, Feng Zhou¹

Affiliations

¹ Department of Gastroenterology, Zhongnan Hospital of Wuhan University, Hubei Clinical Center and Key Laboratory for Intestinal and Colorectal Diseases, Wuhan, China.
² Department of Pathology, Zhongnan Hospital of Wuhan University, Wuhan, China.

Abstract

Plexiform fibromyxoma (PF) is a rare mesenchymal tumor of which the pathogenesis and molecular changes are still unclear. Histologically, it is characterized by a cluster of bland spindle or ovoid cells growing in the mucoid or fibromyxoid stroma rich in small blood vessels. At present, surgical resection is the primary treatment for PF.

Keywords: case report; endoscopic submucosal excavation (ESE); mesenchymal tumor; plexiform fibromyxoma (PF); systematic review.

Publication types

Case Reports

Grants and funding

This work was supported by National Natural Science Foundation of China (grant number 82070569).